doi:10.1056/NEJMoa2204601 Haddad F, Dokmak G, Bader M, et al
In the ATTAIN-1 trial, participants on 12 mg dose lost an average of 8.4% of their body weight over 72 weeks, compared with 2.1% for placebo (2)
Medication is not required to participate in our weight management program
"But if I'm looking at a screen, it's way easier for me to see the definition I have around my waist, or see how much slenderer my thighs are." Sarwer says this isn't uncommon
TNF Pharmaceuticals Launches Study Series aimed at preserving lean muscle mass during GLP-1 Weight Loss treatment | American Pharmaceutical Review - the review of American Pharmaceutical Business & Technology
Many times, you dont even have the full ingredient list on hand, nor do you have any idea where they were manufactured and under what levels of quality control.Combine that with a lack of formal studies or obligation to disclose side effects, and its difficult to know what you may be getting into